Table 3.
Stromal tumour infiltrating lymphocytes (sTILs)-stromal cells co-occurrence | Intratumoural tumour infiltrating lymphocytes (tTILs)-tumour cells co-occurrence | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Discovery set | Test set | External validation cohort | Discovery set | Test set | External validation cohort | |||||||
Characteristics | Mean Rank | p-value | Mean Rank | p-value | Mean Rank | p-value | Mean Rank | p-value | Mean Rank | p-value | Mean Rank | p-value |
Age at diagnosis (years) | ||||||||||||
< 50 | 943 | < 0.001 | 371 | 0.01 | 171 | 0.4 | 886 | < 0.001 | 371 | 0.01 | 160 | 0.9 |
≥ 50 | 749 | 322 | 158 | 751 | 322 | 159 | ||||||
Menopausal status | ||||||||||||
Premenopausal | 906 | < 0.001 | 380 | < 0.001 | NA | NA | 849 | < 0.001 | 364 | 0.01 | NA | NA |
Postmenopausal | 749 | 317 | 755 | 322 | ||||||||
Tumour size (cm) | ||||||||||||
< 2 | 721 | <0.001 | 298 | <0.001 | 147 | 0.004 | 714 | <0.001 | 304 | <0.001 | 141 | < 0.001 |
≥ 2 | 962 | 402 | 177 | 950 | 388 | 186 | ||||||
Tumour grade | ||||||||||||
1 | 611 | < 0.001 | 265 | < 0.001 | 128 | <0.001 | 569 | < 0.001 | 262 | < 0.001 | 123 | <0.001 |
2 | 766 | 328 | 170 | 760 | 327 | 173 | ||||||
3 | 1045 | 418 | 212 | 1062 | 424 | 214 | ||||||
Mitotic count | ||||||||||||
1 | 713 | < 0.001 | 300 | < 0.001 | 149 | <0.001 | 694 | < 0.001 | 298 | < 0.001 | 145 | <0.001 |
2 | 926 | 401 | 196 | 906 | 393 | 216 | ||||||
3 | 1070 | 420 | 202 | 1129 | 448 | 208 | ||||||
Nuclear pleomorphism | ||||||||||||
1 | 365 | < 0.001 | 255 | < 0.001 | 188 | <0.001 | 545 | < 0.001 | 158 | < 0.001 | 157 | <0.001 |
2 | 659 | 281 | 141 | 666 | 299 | 144 | ||||||
3 | 927 | 390 | 192 | 897 | 372 | 187 | ||||||
Tubule formation | ||||||||||||
1 | 590 | < 0.001 | 261 | 0.004 | 138 | 0.07 | 520 | < 0.001 | 245 | < 0.001 | 131 | 0.006 |
2 | 794 | 327 | 156 | 732 | 324 | 153 | ||||||
3 | 814 | 344 | 171 | 842 | 349 | 176 | ||||||
Nottingham Prognostic Index | ||||||||||||
Good prognostic group | 672 | < 0.001 | 284 | < 0.001 | 141 | <0.001 | 665 | < 0.001 | 289 | < 0.001 | 138 | <0.001 |
Moderate prognostic group | 930 | 385 | 194 | 916 | 381 | 198 | ||||||
Poor prognostic group | 1173 | 450 | 193 | 1206 | 378 | 271 | ||||||
Histological types | ||||||||||||
No special type (NST) | 862 | < 0.001 | 350 | < 0.001 | 166 | 0.002 | 873 | < 0.001 | 362 | < 0.001 | 169 | 0.005 |
Lobular | 666 | 298 | 154 | 629 | 262 | 142 | ||||||
Other special types | 494 | 194 | 110 | 405 | 195 | 106 | ||||||
Mixed NST and other tumour types | 750 | 332 | 156 | 721 | 320 | 160 | ||||||
Lymphovascular invasion | ||||||||||||
Negative | 765 | < 0.001 | 322 | 0.003 | 155 | <0.001 | 758 | < 0.001 | 329 | 0.6 | 155 | <0.001 |
Positive | 933 | 388 | 236 | 912 | 338 | 237 | ||||||
Lymph node status | ||||||||||||
Negative | 767 | < 0.001 | 323 | 0.06 | 157 | 0.1 | 763 | 0.009 | 326 | 0.2 | 155 | 0.04 |
Positive | 866 | 357 | 177 | 837 | 345 | 189 | ||||||
Progesterone receptor | ||||||||||||
Negative | 815 | 0.2 | 360 | 0.05 | 159 | 0.9 | 757 | 0.3 | 339 | 0.5 | 138 | 0.2 |
Positive | 780 | 323 | 160 | 782 | 328 | 162 | ||||||
Ki67 index | ||||||||||||
Low ( < 20%) | 301 | < 0.001 | 140 | < 0.001 | NA | NA | 297 | < 0.001 | 140 | < 0.001 | NA | NA |
High ( ≥ 20%) | 414 | 183 | 409 | 182 |
NA not applicable.
Significant p-values are in bold (Mann-Whitney test).